Literature DB >> 18199531

Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors.

Aime T Franco1, Elizabeth Johnston, Uma Krishna, Yoshio Yamaoka, Dawn A Israel, Toni A Nagy, Lydia E Wroblewski, Maria Blanca Piazuelo, Pelayo Correa, Richard M Peek.   

Abstract

Helicobacter pylori is the strongest known risk factor for gastric adenocarcinoma, and strains that possess the cag secretion system, which translocates the bacterial effector CagA into host cells, augment cancer risk. H. pylori strains that express the vacuolating cytotoxin or the outer membrane protein OipA are similarly associated with severe pathologic outcomes. We previously reported that an in vivo adapted H. pylori strain, 7.13, induces gastric adenocarcinoma in rodent models of gastritis. In the current study, we used carcinogenic strain 7.13 as a prototype to define the role of virulence constituents in H. pylori-mediated carcinogenesis. Mongolian gerbils were infected with wild-type strain 7.13 or cagA(-), vacA(-), or oipA(-) mutants for 12 to 52 weeks. All infected gerbils developed gastritis; however, inflammation was significantly attenuated in animals infected with the cagA(-) but not the vacA(-) or oipA(-) strains. Gastric dysplasia and cancer developed in >50% of gerbils infected with either the wild-type or vacA(-) strain but in none of the animals infected with the cagA(-) strain. Inactivation of oipA decreased beta-catenin nuclear localization in vitro and reduced the incidence of cancer in gerbils. OipA expression was detected significantly more frequently among H. pylori strains isolated from human subjects with gastric cancer precursor lesions versus persons with gastritis alone. These results indicate that loss of CagA prevents the development of cancer in this model. Inactivation of oipA attenuates beta-catenin nuclear translocation and also decreases the incidence of carcinoma. In addition to defining factors that mediate H. pylori-induced cancer, these results provide insight into mechanisms that may regulate the development of other malignancies arising within the context of inflammatory states.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18199531      PMCID: PMC3114460          DOI: 10.1158/0008-5472.CAN-07-0824

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  50 in total

1.  SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein.

Authors:  Hideaki Higashi; Ryouhei Tsutsumi; Syuichi Muto; Toshiro Sugiyama; Takeshi Azuma; Masahiro Asaka; Masanori Hatakeyama
Journal:  Science       Date:  2001-12-13       Impact factor: 47.728

2.  The evaluation of putative virulence factors of Helicobacter pylori for gastroduodenal disease by use of a short-term Mongolian gerbil infection model.

Authors:  Masao Akanuma; Shin Maeda; Keiji Ogura; Yuzo Mitsuno; Yoshihiro Hirata; Tsuneo Ikenoue; Motoyuki Otsuka; Takeshi Watanabe; Yutaka Yamaji; Haruhiko Yoshida; Takao Kawabe; Yasushi Shiratori; Masao Omata
Journal:  J Infect Dis       Date:  2002-01-17       Impact factor: 5.226

Review 3.  Helicobacter pylori and gastrointestinal tract adenocarcinomas.

Authors:  Richard M Peek; Martin J Blaser
Journal:  Nat Rev Cancer       Date:  2002-01       Impact factor: 60.716

4.  Interleukin-1 polymorphisms associated with increased risk of gastric cancer.

Authors:  E M El-Omar; M Carrington; W H Chow; K E McColl; J H Bream; H A Young; J Herrera; J Lissowska; C C Yuan; N Rothman; G Lanyon; M Martin; J F Fraumeni; C S Rabkin
Journal:  Nature       Date:  2000-03-23       Impact factor: 49.962

5.  Lipopolysaccharide activates Akt in human alveolar macrophages resulting in nuclear accumulation and transcriptional activity of beta-catenin.

Authors:  M M Monick; A B Carter; P K Robeff; D M Flaherty; M W Peterson; G W Hunninghake
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

6.  A M(r) 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori.

Authors:  Y Yamaoka; D H Kwon; D Y Graham
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

7.  Polymorphisms of Helicobacter pylori HP0638 reflect geographic origin and correlate with cagA status.

Authors:  T Ando; R M Peek; D Pride; S M Levine; T Takata; Y-C Lee; K Kusugami; A van der Ende; E J Kuipers; J G Kusters; M J Blaser
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

8.  cag+ Helicobacter pylori induce transactivation of the epidermal growth factor receptor in AGS gastric epithelial cells.

Authors:  S Keates; S Sougioultzis; A C Keates; D Zhao; R M Peek; L M Shaw; C P Kelly
Journal:  J Biol Chem       Date:  2001-10-16       Impact factor: 5.157

9.  Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma.

Authors:  J C Machado; P Pharoah; S Sousa; R Carvalho; C Oliveira; C Figueiredo; A Amorim; R Seruca; C Caldas; F Carneiro; M Sobrinho-Simões
Journal:  Gastroenterology       Date:  2001-10       Impact factor: 22.682

10.  Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbil.

Authors:  K Ogura; S Maeda; M Nakao; T Watanabe; M Tada; T Kyutoku; H Yoshida; Y Shiratori; M Omata
Journal:  J Exp Med       Date:  2000-12-04       Impact factor: 14.307

View more
  140 in total

1.  Spermine oxidase mediates the gastric cancer risk associated with Helicobacter pylori CagA.

Authors:  Rupesh Chaturvedi; Mohammad Asim; Judith Romero-Gallo; Daniel P Barry; Svea Hoge; Thibaut de Sablet; Alberto G Delgado; Lydia E Wroblewski; M Blanca Piazuelo; Fang Yan; Dawn A Israel; Robert A Casero; Pelayo Correa; Alain P Gobert; D Brent Polk; Richard M Peek; Keith T Wilson
Journal:  Gastroenterology       Date:  2011-08-10       Impact factor: 22.682

2.  Silencing of miR490-3p by H. pylori activates DARPP-32 and induces resistance to gefitinib.

Authors:  Shoumin Zhu; Shayan Khalafi; Zheng Chen; Julio Poveda; Dunfa Peng; Heng Lu; Mohammed Soutto; Jianwen Que; Monica Garcia-Buitrago; Alexander Zaika; Wael El-Rifai
Journal:  Cancer Lett       Date:  2020-07-29       Impact factor: 8.679

3.  Helicobacter pylori γ-glutamyl transpeptidase and vacuolating cytotoxin promote gastric persistence and immune tolerance.

Authors:  Mathias Oertli; Manuel Noben; Daniela B Engler; Raphaela P Semper; Sebastian Reuter; Joachim Maxeiner; Markus Gerhard; Christian Taube; Anne Müller
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

4.  TLR9 activation suppresses inflammation in response to Helicobacter pylori infection.

Authors:  Matthew G Varga; M Blanca Piazuelo; Judith Romero-Gallo; Alberto G Delgado; Giovanni Suarez; Morgan E Whitaker; Uma S Krishna; Rachna V Patel; Eric P Skaar; Keith T Wilson; Holly M S Algood; Richard M Peek
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-10-06       Impact factor: 4.052

Review 5.  H. pylori infection, inflammation and gastric cancer.

Authors:  Qurteeba Qadri; Roohi Rasool; G M Gulzar; Sameer Naqash; Zafar A Shah
Journal:  J Gastrointest Cancer       Date:  2014-06

6.  Iron deficiency accelerates Helicobacter pylori-induced carcinogenesis in rodents and humans.

Authors:  Jennifer M Noto; Jennifer A Gaddy; Josephine Y Lee; M Blanca Piazuelo; David B Friedman; Daniel C Colvin; Judith Romero-Gallo; Giovanni Suarez; John Loh; James C Slaughter; Shumin Tan; Douglas R Morgan; Keith T Wilson; Luis E Bravo; Pelayo Correa; Timothy L Cover; Manuel R Amieva; Richard M Peek
Journal:  J Clin Invest       Date:  2012-12-21       Impact factor: 14.808

7.  Helicobacter pylori cytotoxin-associated gene A activates the signal transducer and activator of transcription 3 pathway in vitro and in vivo.

Authors:  Dana M Bronte-Tinkew; Mauricio Terebiznik; Aime Franco; Michelle Ang; Diane Ahn; Hitomi Mimuro; Chihiro Sasakawa; Mark J Ropeleski; Richard M Peek; Nicola L Jones
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

Review 8.  Gastrin, inflammation, and carcinogenesis.

Authors:  Celia Chao; Mark R Hellmich
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2010-02       Impact factor: 3.243

9.  Helicobacter pylori and EBV in gastric carcinomas: methylation status and microsatellite instability.

Authors:  Adriana Camargo Ferrasi; Nídia Alice Pinheiro; Silvia Helena Barem Rabenhorst; Otávia Luisa Caballero; Maria Aparecida Marchesan Rodrigues; Fabrício de Carvalho; Celso Vieira de Souza Leite; Marcia Valéria Pitombeira Ferreira; Marcos Aurélio Pessoa Barros; Maria Inês Moura Campos Pardini
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

10.  Carcinogenic Helicobacter pylori Strains Selectively Dysregulate the In Vivo Gastric Proteome, Which May Be Associated with Stomach Cancer Progression.

Authors:  Jennifer M Noto; Kristie L Rose; Amanda J Hachey; Alberto G Delgado; Judith Romero-Gallo; Lydia E Wroblewski; Barbara G Schneider; Shailja C Shah; Timothy L Cover; Keith T Wilson; Dawn A Israel; Juan Carlos Roa; Kevin L Schey; Yana Zavros; M Blanca Piazuelo; Richard M Peek
Journal:  Mol Cell Proteomics       Date:  2018-11-19       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.